Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact

Table of Contents

September 30, 2017 ;  102 (10)

Editorial

  • You have access
    Rapamycin targets several pathophysiological features of immune-mediated bone marrow failure in murine models
    Wendy W. Weston, Vesna Jurecic, Roland Jurecic
    Haematologica October 2017 102: 1627-1628; doi:10.3324/haematol.2017.175497
    • Disclosures and Contributions

Review Article

  • Open Access
    Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach
    Iris de Weerdt, Suzanne M. Koopmans, Arnon P. Kater, Michel van Gelder
    Haematologica October 2017 102: 1629-1639; doi:10.3324/haematol.2017.164103
    • Disclosures and Contributions

Articles

  • Iron Metabolism & its Disorders

    • Open Access
      Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin
      Maciej W. Garbowski, Patricia Evans, Evangelia Vlachodimitropoulou, Robert Hider, John B. Porter
      Haematologica October 2017 102: 1640-1649; doi:10.3324/haematol.2017.170605
      • Garbowski et al. Supplementary Appendix
      • Disclosures and Contributions
  • Blood Transfusion

    • Open Access
      Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance
      Simona Stivala, Sara Gobbato, Laura Infanti, Martin F. Reiner, Nicole Bonetti, Sara C. Meyer, Giovanni G. Camici, Thomas F. Lüscher, Andreas Buser, Jürg H. Beer
      Haematologica October 2017 102: 1650-1660; doi:10.3324/haematol.2017.164137
      • Stivala et at. Graphical Abstract
      • Stivala et al. Supplementary Appendix
      • Disclosures and Contributions
  • Platelet Biology & its Disorders

    • Open Access
      Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation
      Rashmi Kanagal-Shamanna, Sanam Loghavi, Courtney D. DiNardo, L. Jeffrey Medeiros, Guillermo Garcia-Manero, Elias Jabbour, Mark J. Routbort, Rajyalakshmi Luthra, Carlos E. Bueso-Ramos, Joseph D. Khoury
      Haematologica October 2017 102: 1661-1670; doi:10.3324/haematol.2017.167726
      • Kanagal-Shamanna et al. Supplementary Appendix
      • Disclosures and Contributions
  • Bone Marrow Failure

    • Open Access
      Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1
      Jennifer Vandooren, Wannes Swinnen, Estefania Ugarte-Berzal, Lise Boon, Daphne Dorst, Erik Martens, Ghislain Opdenakker
      Haematologica October 2017 102: 1671-1682; doi:10.3324/haematol.2017.168799
      • Vandooren et al. Supplementary Appendix
      • Disclosures and Contributions
    • Open Access
      Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000–2011
      Krista Vaht, Magnus Göransson, Kristina Carlson, Cecilia Isaksson, Stig Lenhoff, Anna Sandstedt, Bertil Uggla, Jacek Winiarski, Per Ljungman, Mats Brune, Per-Ola Andersson
      Haematologica October 2017 102: 1683-1690; doi:10.3324/haematol.2017.169862
      • Vaht et al. Supplementary Appendix
      • Disclosures and Contributions
    • Open Access
      Rapamycin is highly effective in murine models of immune-mediated bone marrow failure
      Xingmin Feng, Zenghua Lin, Wanling Sun, Maile K. Hollinger, Marie J. Desierto, Keyvan Keyvanfar, Daniela Malide, Pawel Muranski, Jichun Chen, Neal S. Young
      Haematologica October 2017 102: 1691-1703; doi:10.3324/haematol.2017.163675
      • Feng et al. Graphical Abstract
      • Feng et al. Supplementary Appendix
      • Disclosures and Contributions
  • Chronic Myeloid Leukemia

    • Open Access
      Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents
      Frédéric Millot, Joëlle Guilhot, Meinolf Suttorp, Adalet Meral Güneş, Petr Sedlacek, Eveline De Bont, Chi Kong Li, Krzysztof Kalwak, Birgitte Lausen, Srdjana Culic, Michael Dworzak, Emilia Kaiserova, Barbara De Moerloose, Farah Roula, Andrea Biondi, André Baruchel
      Haematologica October 2017 102: 1704-1708; doi:10.3324/haematol.2017.170035
      • Disclosures and Contributions
  • Acute Myeloid Leukemia

    • Open Access
      Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome
      Naval Daver, Hagop Kantarjian, Guillermo Garcia-Manero, Elias Jabbour, Gautam Borthakur, Mark Brandt, Sherry Pierce, Kenneth Vaughan, Jing Ning, Graciela M. Nogueras González, Keyur Patel, Jeffery Jorgensen, Naveen Pemmaraju, Tapan Kadia, Marina Konopleva, Michael Andreeff, Courtney DiNardo, Jorge Cortes, Renee Ward, Adam Craig, Farhad Ravandi
      Haematologica October 2017 102: 1709-1717; doi:10.3324/haematol.2017.168732
      • Daver et al. Supplementary Appendix
      • Disclosures and Contributions
    • Open Access
      Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients
      Etienne De Clara, Morgane Gourvest, Hanjing Ma, François Vergez, Marie Tosolini, Sébastien Dejean, Cécile Demur, Eric Delabesse, Christian Recher, Christian Touriol, Maria Paola Martelli, Brunangelo Falini, Pierre Brousset, Marina Bousquet
      Haematologica October 2017 102: 1718-1726; doi:10.3324/haematol.2017.171645
      • De Clara et al. Supplementary Appendix
      • Disclosures and Contributions
  • Acute Lymphoblastic Leukemia

    • Open Access
      Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951
      Veerle Mondelaers, Stefan Suciu, Barbara De Moerloose, Alina Ferster, Françoise Mazingue, Geneviève Plat, Karima Yakouben, Anne Uyttebroeck, Patrick Lutz, Vitor Costa, Nicolas Sirvent, Emmanuel Plouvier, Martine Munzer, Maryline Poirée, Odile Minckes, Frédéric Millot, Dominique Plantaz, Philip Maes, Claire Hoyoux, Hélène Cavé, Pierre Rohrlich, Yves Bertrand, Yves Benoit
      Haematologica October 2017 102: 1727-1738; doi:10.3324/haematol.2017.165845
      • Mondelaers et al. Supplementary Appendix
      • Disclosures and Contributions
    • Open Access
      Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia
      Benjamin Kobitzsch, Nicola Gökbuget, Stefan Schwartz, Richard Reinhardt, Monika Brüggemann, Andreas Viardot, Ralph Wäsch, Michael Starck, Eckhard Thiel, Dieter Hoelzer, Thomas Burmeister
      Haematologica October 2017 102: 1739-1747; doi:10.3324/haematol.2016.161273
      • Kobitzsch et al. Supplementary Appendix
      • Disclosures and Contributions
  • Hodgkin Lymphoma

    • Open Access
      Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials
      Dennis A. Eichenauer, Ingrid Becker, Ina Monsef, Nicholas Chadwick, Vitaliana de Sanctis, Massimo Federico, Catherine Fortpied, Alessandro M. Gianni, Michel Henry-Amar, Peter Hoskin, Peter Johnson, Stefano Luminari, Monica Bellei, Alessandro Pulsoni, Matthew R. Sydes, Pinuccia Valagussa, Simonetta Viviani, Andreas Engert, Jeremy Franklin
      Haematologica October 2017 102: 1748-1757; doi:10.3324/haematol.2017.167478
      • Eichenauer et al. Graphical Abstract
      • Disclosures and Contributions
      • Eichenauer et al. Supplementary Appendix
  • Non-Hodgkin Lymphoma

    • Open Access
      Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma
      Laurent Jallades, Lucile Baseggio, Pierre Sujobert, Sarah Huet, Kaddour Chabane, Evelyne Callet-Bauchu, Aurélie Verney, Sandrine Hayette, Jean-Pierre Desvignes, David Salgado, Nicolas Levy, Christophe Béroud, Pascale Felman, Françoise Berger, Jean-Pierre Magaud, Laurent Genestier, Gilles Salles, Alexandra Traverse-Glehen
      Haematologica October 2017 102: 1758-1766; doi:10.3324/haematol.2016.160192
      • Jallades et al. Graphical Abstract
      • Jallades et al. Supplementary Appendix
      • Disclosures and Contributions
  • Plasma Cell Disorders

    • Open Access
      Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
      María-Victoria Mateos, Tamas Masszi, Norbert Grzasko, Markus Hansson, Irwindeep Sandhu, Ludek Pour, Luísa Viterbo, Sharon R. Jackson, Anne-Marie Stoppa, Peter Gimsing, Mehdi Hamadani, Gabriela Borsaru, Deborah Berg, Jianchang Lin, Alessandra Di Bacco, Helgi van de Velde, Paul G. Richardson, Philippe Moreau
      Haematologica October 2017 102: 1767-1775; doi:10.3324/haematol.2017.170118
      • Mateos et al. Graphical Abstract
      • Mateos et al. Supplementary Appendix
      • Disclosures and Contributions
    • Open Access
      The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling
      Tania Díaz, Vanina Rodríguez, Ester Lozano, Mari-Pau Mena, Marcos Calderón, Laura Rosiñol, Antonio Martínez, Natalia Tovar, Patricia Pérez-Galán, Joan Bladé, Gaël Roué, Carlos Fernández de Larrea
      Haematologica October 2017 102: 1776-1784; doi:10.3324/haematol.2017.164632
      • Diaz et al. Supplementary Appendix
      • Disclosures and Contributions
  • Cell Therapy & Immunotherapy

    • Open Access
      Notch2 blockade enhances hematopoietic stem cell mobilization and homing
      Weihuan Wang, Shuiliang Yu, Jay Myers, Yiwei Wang, William W. Xin, Marwah Albakri, Alison W. Xin, Ming Li, Alex Y. Huang, Wei Xin, Christian W. Siebel, Hillard M. Lazarus, Lan Zhou
      Haematologica October 2017 102: 1785-1795; doi:10.3324/haematol.2017.168674
      • Wang et al. Supplementary Appendix
      • Disclosures and Contributions
  • Complications in Hematology

    • Open Access
      Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
      Jennifer R. Brown, Javid Moslehi, Susan O’Brien, Paolo Ghia, Peter Hillmen, Florence Cymbalista, Tait D. Shanafelt, Graeme Fraser, Simon Rule, Thomas J. Kipps, Steven Coutre, Marie-Sarah Dilhuydy, Paula Cramer, Alessandra Tedeschi, Ulrich Jaeger, Martin Dreyling, John C. Byrd, Angela Howes, Michael Todd, Jessica Vermeulen, Danelle F. James, Fong Clow, Lori Styles, Rudy Valentino, Mark Wildgust, Michelle Mahler, Jan A. Burger
      Haematologica October 2017 102: 1796-1805; doi:10.3324/haematol.2017.171041
      • Brown et al. Supplementary Appendix
      • Disclosures and Contributions

Letters to the Editor

  • You have access
    Temporal contribution of the platelet body and balloon to thrombin generation
    Ejaife O. Agbani, Ingeborg Hers, Alastair W. Poole
    Haematologica October 2017 102: e379-e381; doi:10.3324/haematol.2017.166819
    • Agbani et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Long-term risk of cancer development in adult patients with idiopathic aplastic anemia after treatment with anti-thymocyte globulin
    Joost G.K. van der Hem, Liesbeth C. de Wreede, Anneke Brand, Hendrik Veelken, J.H. Frederik Falkenburg, Constantijn J.M. Halkes
    Haematologica October 2017 102: e382-e383; doi:10.3324/haematol.2017.171215
    • Disclosures and Contributions
  • You have access
    Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms
    Jennifer Huberty, Ryan Eckert, Krisstina Gowin, Jules Mitchell, Amylou C. Dueck, Brenda F. Ginos, Linda Larkey, Ruben Mesa
    Haematologica October 2017 102: e384-e388; doi:10.3324/haematol.2017.168583
    • Disclosures and Contributions
  • You have access
    Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 axis
    Bob de Rooij, Roel Polak, Lieke C.J. van den Berk, Femke Stalpers, Rob Pieters, Monique L. den Boer
    Haematologica October 2017 102: e389-e393; doi:10.3324/haematol.2016.159517
    • de Rooij et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia
    Elisa ten Hacken, Maria Gounari, Jaap Willem Back, Ekaterina Shimanovskaya, Lydia Scarfò, Ekaterina Kim, Jared Burks, Maurilio Ponzoni, Giuseppe Alvise Ramirez, William G. Wierda, Zeev Estrov, Michael J. Keating, Alessandra Ferrajoli, Kostas Stamatopoulos, Paolo Ghia, Jan A. Burger
    Haematologica October 2017 102: e394-e396; doi:10.3324/haematol.2017.169102
    • ten Hacken et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Ibrutinib may impair serological responses to influenza vaccination
    Abby P. Douglas, Jason A. Trubiano, Ian Barr, Vivian Leung, Monica A. Slavin, Constantine S. Tam
    Haematologica October 2017 102: e397-e399; doi:10.3324/haematol.2017.164285
    • Disclosures and Contributions
  • You have access
    The specific Bruton tyrosine kinase inhibitor acalabrutinib (ACP-196) shows favorable in vitro activity against chronic lymphocytic leukemia B cells with CD20 antibodies
    Josée Golay, Greta Ubiali, Martino Introna
    Haematologica October 2017 102: e400-e403; doi:10.3324/haematol.2017.169334
    • Golay et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay
    Jean-Philippe Jais, Thierry Jo Molina, Philippe Ruminy, David Gentien, Cecile Reyes, David W. Scott, Lisa M. Rimsza, George Wright, Randy D. Gascoyne, Louis M. Staudt, Corinne Haioun, Herve Tilly, Philippe Gaulard, Gilles A. Salles, Fabrice Jardin, Karen Leroy
    Haematologica October 2017 102: e404-e406; doi:10.3324/haematol.2017.166827
    • Jais et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report
    Livio Pagano, Giulia Dragonetti, Chiara Cattaneo, Francesco Marchesi, Barbara Veggia, Alessandro Busca, Anna Candoni, Lucia Prezioso, Marianna Criscuolo, Simone Cesaro, Mario Delia, Rosa Fanci, Marta Stanzani, Antonella Ferrari, Bruno Martino, Lorella Melillo, Gianpaolo Nadali, Edoardo Simonetti, Stelvio Ballanti, Marco Picardi, Carlo Castagnola, Nunzia Decembrino, Marco Gazzola, Nicola Stefano Fracchiolla, Valentina Mancini, Annamaria Nosari, Maria Ilaria Del Principe, Franco Aversa, Mario Tumbarello
    Haematologica October 2017 102: e407-e410; doi:10.3324/haematol.2017.172536
    • Disclosures and Contributions
  • You have access
    Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts
    Iman Meziane, Stefanie Huhn, Miguel Inacio da Silva Filho, Niels Weinhold, Chiara Campo, Jolanta Nickel, Per Hoffmann, Markus M. Nöthen, Karl-Heinz Jöckel, Stefano Landi, Jonathan S. Mitchell, David Johnson, Anna Jauch, Gareth J. Morgan, Richard Houlston, Hartmut Goldschmidt, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Asta Försti, Stefan O. Schönland, Kari Hemminki
    Haematologica October 2017 102: e411-e414; doi:10.3324/haematol.2017.171108
    • Meziane et al. Supplementary Appendix
    • Disclosures and Contributions

Case Reports

  • You have access
    Red blood cell Gardos channel (KCNN4): the essential determinant of erythrocyte dehydration in hereditary xerocytosis
    Raphaël Rapetti-Mauss, Véronique Picard, Corinne Guitton, Khaldoun Ghazal, Valérie Proulle, Catherine Badens, Olivier Soriani, Loïc Garçon, Hélène Guizouarn
    Haematologica October 2017 102: e415-e418; doi:10.3324/haematol.2017.171389
    • Rapetti-Mauss et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    An immunocompetent patient with a recurrence-free Epstein-Barr virus positive plasmacytoma possesses robust Epstein-Barr virus specific T-cell responses
    Bithi Chatterjee, Laura Sahli, Obinna Chijioke, Philip Went, Christian Münz, Andreas Trojan
    Haematologica October 2017 102: e419-e422; doi:10.3324/haematol.2017.172791
    • Chatterjee et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reports
    Glenda Grossi, Mauro Viganò, Floriana Facchetti, Sara Labanca, Alessandro Loglio, Anna Dodero, Vittorio Montefusco, Paolo Corradini, Anna Cafro, Roberto Cairoli, Massimo Colombo, Pietro Lampertico
    Haematologica October 2017 102: e423-e426; doi:10.3324/haematol.2017.168609
    • Disclosures and Contributions
Back to top
PreviousNext

In this issue

Haematologica: 102 (10)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Jump to

  • Editorial
  • Review Article
  • Articles
  • Iron Metabolism & its Disorders
  • Blood Transfusion
  • Platelet Biology & its Disorders
  • Bone Marrow Failure
  • Chronic Myeloid Leukemia
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • Plasma Cell Disorders
  • Cell Therapy & Immunotherapy
  • Complications in Hematology
  • Letters to the Editor
  • Case Reports

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

 
Loading
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online